First Evidence: Brain Enzyme Self-Modifies to Control Sugar Chain Production
A brain enzyme has been caught self-modifying to build polysialic acid, a sugar chain critical for brain development. The discovery overturns decades of assumptions about enzyme regulation.
In a twist that challenges decades of scientific understanding, researchers at Nagoya University have discovered that a brain enzyme can build polysialic acid—a sugar chain vital for brain development—on itself. This unexpected self-modification, followed by secretion and reactivation outside the cell, reveals a novel mechanism for enzyme regulation. The finding, published in the Journal of Biological Chemistry, could reshape how we study brain function and enzyme behavior.
- The enzyme builds polysialic acid on itself, a process never before observed.
- This mechanism overturns a 50-year-old assumption about enzyme regulation.
- Next steps include exploring therapeutic applications for neurological conditions.
- This discovery could unlock new approaches to studying brain function.
What Happened
Researchers at Nagoya University stumbled upon this discovery while studying the enzyme ST8SIA2, which was thought to only modify proteins. Instead, they found it could attach polysialic acid—a sugar chain essential for brain plasticity and development—directly to itself. This self-modification causes the enzyme to be secreted from the cell, where it remains inactive until the sugar chain is removed. The team used advanced biochemical techniques to confirm this process, including mass spectrometry to identify the precise molecular changes. This finding contradicts the long-held belief that enzymes only modify other molecules, not themselves.
The Bigger Picture
This discovery has far-reaching implications for neuroscience and biochemistry. Polysialic acid plays a crucial role in brain plasticity, the brain’s ability to adapt and rewire itself. Understanding how its production is regulated could lead to breakthroughs in treating neurological disorders like Alzheimer’s and epilepsy. Additionally, the enzyme’s ability to self-modify suggests that other enzymes might have similar hidden capabilities. “This challenges our fundamental understanding of enzyme behavior,” said Dr. Hiroshi Kitagawa, a biochemist at Nagoya University and co-author of the study. “It opens up a new frontier in biochemistry.”
What Comes Next
The next phase of research will focus on exploring the therapeutic potential of this mechanism. Scientists aim to develop drugs that can modulate polysialic acid production, potentially treating conditions like brain injuries or neurodegenerative diseases. However, challenges remain, including understanding how this process interacts with other cellular mechanisms. Researchers estimate that clinical applications could be developed within the next decade, offering hope for patients with currently untreatable brain disorders.
Q: What is polysialic acid?
Polysialic acid is a sugar chain crucial for brain development and plasticity, enabling neurons to adapt and form new connections.
Q: Why is this discovery significant?
It overturns a long-standing assumption about enzymes and could lead to new treatments for brain disorders.
